Molecular Mechanisms Involved in the Synergistic Activation of Soluble Guanylyl Cyclase by YC-1 and Nitric Oxide in Endothelial Cells
- 1Institut für Pharmakologie und Toxikologie, Karl-Franzens-Universität Graz, Graz, Austria (K.S., A.S., B.M.), and 2Institut für Pharmakologie und Toxikologie, Ruhr-Universität Bochum, Bochum, Germany (D.K.)
Abstract
YC-1 is a direct activator of soluble guanylyl cyclase (sGC) and sensitizes the enzyme for activation by nitric oxide (NO) and CO. Because the potentiating effect of YC-1 on NO-induced cGMP formation in platelets and smooth muscle cells has been shown to be substantially higher than observed with the purified enzyme, the synergism between heme ligands and YC-1 is apparently more pronounced in intact cells than in cell-free systems. Here, we investigated the mechanisms underlying the synergistic activation of sGC by YC-1 and NO in endothelial cells. Stimulation of the cells with YC-1 enhanced cGMP accumulation up to ∼100-fold. The maximal effect of YC-1 was more pronounced than that of the NO donor DEA/NO (∼20-fold increase in cGMP accumulation) and markedly diminished in the presence ofl-NG-nitroarginine, EGTA, or oxyhemoglobin. Because YC-1 did not activate endothelial NO synthase, the pronounced effect of YC-1 on cGMP accumulation was apparently caused by a synergistic activation of sGC by YC-1 and basal NO. The effect of YC-1 was further enhanced by addition of DEA/NO, resulting in a ∼160-fold stimulation of cGMP accumulation. Thus, YC-1 increased the NO-induced accumulation of cGMP in intact cells by ∼8-fold. Addition of endothelial cell homogenate increased the stimulatory effect of YC-1 on NO-activated purified sGC from 1.2- to 3.7-fold. This effect was not observed with heat-denatured homogenates, suggesting that a heat-labile factor present in endothelial cells potentiates the effect of YC-1 on NO-activated sGC.
Footnotes
-
Send reprint requests to: Dr. Kurt Schmidt, Institut für Pharmakologie und Toxikologie, Karl-Franzens-Universität Graz, Universitätsplatz 2, A-8010 Graz, Austria. E-mail: kurt.schmidt{at}kfunigraz.ac.at
-
This work was supported by Austrian Science Fund Grants P12191 (to K.S.) and P13586 (to B.M.).
- Abbreviations:
- sGC
- soluble guanylyl cyclase
- NO
- nitric oxide
- NOS
- nitric-oxide synthase
- eNOS
- endothelial nitric-oxide synthase
- PDE
- phosphodiesterase
- DMSO
- dimethyl sulfoxide
- IBMX
- 3-isobutyl-1-methylxanthine
- l-NNA
- l-NG-nitroarginine
- OxyHb
- oxyhemoglobin
- DEA/NO
- 2,2-diethyl-1-nitroso-oxyhydrazine
-
- Received May 22, 2000.
- Accepted October 11, 2000.
- The American Society for Pharmacology and Experimental Therapeutics



